Video

Genetic Testing for the BRCA Mutation

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of woman.
Rina-S Generates Antitumor Activity in Heavily Pretreated Ovarian Cancer
Sue Friedman in an interview with CURE
More Is Needed to Connect Clinicians, Patients to Clinical Trials
Elahere Symptoms Patients With Ovarian Cancer Should Look Out For
Elahere Symptoms Patients With Ovarian Cancer Should Look Out For
Dr. Alex Francoeur interviewing against a gray CURE background
Palliative Care Decreases Hospital Readmissions in Ovarian Cancer
What Patients and Their Families Should Know About Hereditary Breast Cancer
What Patients and Their Families Should Know About Hereditary Breast Cancer
Support is ‘Critical’ for Those Affected By Hereditary Cancers
Support is ‘Critical’ for Those Affected By Hereditary Cancers
Making Strides and Breaking Down Barriers in Genetic Testing for Breast Cancer
Making Strides and Breaking Down Barriers in Genetic Testing for Breast Cancer
The Value of Partnerships for Hereditary Cancers
The Value of Partnerships for Hereditary Cancers
Clinical Trials in Hereditary Cancer Maybe A Key to Better Health Outcomes
Clinical Trials in Hereditary Cancer Maybe A Key to Better Health Outcomes
'There's a Gift in the Conflict' of Cancer, Says Patrick Dempsey
'There's a Gift in the Conflict' of Cancer, Says Patrick Dempsey
Related Content
Illustration of ovaries.
April 3rd 2025

Development of Nemvaleukin for Platinum-Resistant Ovarian Cancer Halted

Alex Biese
A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on to final analysis.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of ovaries.
March 24th 2025

First Patient Dosed in Phase 3 Trial of IBI354 for Ovarian Cancer

Spencer Feldman
The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.
Shannon Miller smiling at a podium while delivering the keynote address at the 2023 Extraordinary Healer event | Image credit: © ATA-GIRL PHOTOGRAPHY
May 4th 2023

Olympian Shares Her Cancer Experience: ‘Give Yourself Grace’

Brielle Benyon
Olympic gymnast, Shannon Miller, sat down with CURE® to discuss her experience with a rare type of ovarian cancer, and how her competitive mindset helped her through.
Elahere shows consistent survival benefits in patients with folate receptor alpha-positive platinum-resistant ovarian cancer: ©mi_viri - stock.adobe.com.
March 17th 2025

Elahere Shows Consistent Survival Benefit in Ovarian Cancer Subset

Spencer Feldman
Elahere shows consistent survival benefits in patients with folate receptor alpha-positive platinum-resistant ovarian cancer in the MIRASOL trial.
Kelly Irvin was diagnosed with stage 4 ovarian cancer in January 2016. Catch up on all of Kelly's blogs here!
January 29th 2025

Ovarian Cancer Teaches Hard Life Lessons

Kelly Irvin
Having a life-threatening disease reminds me daily to make the most of whatever time I have.